We are live on ! Find out more
TCOT

Trust Company of Toledo Portfolio holdings

AUM $1.2B
1-Year Est. Return 33.38%
This Fund
S&P 500
This Quarter Est. Return
+0.26%
1 Year Est. Return
+33.38%
3 Year Est. Return
+93.78%
5 Year Est. Return
+127.39%
10 Year Est. Return
+336.34%
AUM
$763M
AUM Growth
+$23.7M
Cap. Flow
+$32.4M
Cap. Flow %
4.25%
Top 10 Hldgs %
37.15%
Holding
246
New
7
Increased
117
Reduced
66
Closed
9

Top Sells

Rank Stock Value
1
BLK icon
Blackrock
BLK
+$1.92M
2
LRCX icon
Lam Research
LRCX
+$1.69M
3
INTC icon
Intel
INTC
+$400K
4
WELL icon
Welltower
WELL
+$357K
5
FCX icon
Freeport-McMoran
FCX
+$350K

Sector Composition

Rank Sector Weight
1 Technology 31.27%
2 Healthcare 12.64%
3 Financials 11.62%
4 Industrials 9.75%
5 Consumer Discretionary 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
226
Universal Health Services
UHS
$10.2B
$215K 0.03%
1,200
OC icon
227
Owens Corning
OC
$12.3B
$213K 0.03%
1,250
CSX icon
228
CSX Corp
CSX
$92.8B
$210K 0.03%
6,520
+300
+5% +$10.3K
CAH icon
229
Cardinal Health
CAH
$54.5B
$209K 0.03%
+1,764
New +$206K
DTE icon
230
DTE Energy
DTE
$28.9B
$206K 0.03%
1,706
-41
-2% -$5.06K
TRVI icon
231
Trevi Therapeutics
TRVI
$2.53B
$150K 0.02%
36,502
AUTL
232
Autolus Therapeutics
AUTL
$564M
$85.2K 0.01%
36,265
HFRO
233
Highland Opportunities and Income Fund
HFRO
$398M
$51.9K 0.01%
+10,000
New +$56.6K
IRD
234
Opus Genetics
IRD
$313M
$36.8K ﹤0.01%
30,963
GEG icon
235
Great Elm Group
GEG
$69M
$27.1K ﹤0.01%
15,000
LCTX icon
236
Lineage Cell Therapeutics
LCTX
$278M
$17K ﹤0.01%
33,795
VIRX
237
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.98K ﹤0.01%
12,317
BLK icon
238
Blackrock
BLK
$180B
-2,022
Closed -$1.92M
CTVA icon
239
Corteva
CTVA
$50.4B
-3,658
Closed -$215K
EMN icon
240
Eastman Chemical
EMN
$8.29B
-1,787
Closed -$200K
LRCX icon
241
Lam Research
LRCX
$408B
-20,740
Closed -$1.69M
MUB icon
242
iShares National Muni Bond ETF
MUB
$45.9B
-1,921
Closed -$209K
NEM icon
243
Newmont
NEM
$124B
-4,696
Closed -$251K

Similar funds

Trust Company of Toledo's Q4 2024 Portfolio in Review

As of Q4 2024, Trust Company of Toledo held 246 positions worth $763M, up 3.2% from $739M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trust Company of Toledo deployed $32.4M of net new capital in Q4 2024, opening 7 new positions and adding to 117 existing holdings. Its largest new stake was Cedar Fair: 7,799 shares worth $376K.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Intel, an estimated $400K trimmed.

  • Trust Company of Toledo's largest Q4 2024 buy was Cedar Fair: 7,799 shares worth $376K.
  • Trust Company of Toledo added most to Apple in Q4 2024, an estimated $12.2M increase.
  • Trust Company of Toledo's biggest Q4 2024 reduction was Intel, cutting an estimated $400K.
  • Trust Company of Toledo fully exited Blackrock in Q4 2024, selling an estimated $1.92M.
  • Trust Company of Toledo's ten largest holdings make up 37% of its $763M portfolio in Q4 2024.
  • Trust Company of Toledo opened 7 new positions and closed 9 in Q4 2024.
  • Trust Company of Toledo's portfolio value rose 3.2% quarter-over-quarter to $763M.

Based on Trust Company of Toledo's 13F filing for Q4 2024, filed 13 Jan 2025.